CYP2D6 and breast cancer: Our study aimed at gaining insights into the frequencies of the most clinically relevant CYP2D6 alleles in a cohort of Syrian breast cancer patients and establishing the clinical utility of CYP2D6 genotyping in the prediction of tamoxifen efficacy and occurrence of its side effects.